‘Make Motherhood Great Again’: Pronatalism Finds a Comfortable Home in the Trump Administration
By Shoshanna Ehrlich,
Ms. Magazine
| 04. 15. 2025
Promotional image from Natalism.org
A month into President Donald Trump’s second term, Sean Duffy, the newly appointed secretary of the Department of Transportation (DOT), issued a memo declaring that “DOT-supported or assisted state contracts shall prioritize projects and goals … that give preference to communities with marriage and birth rates higher than the national average.” This move by Duffy—who happens to be a father of seven—tying federal transportation spending to birth and marriage rates was characterized as “disturbingly dystopian” by Sen. Patty Murray (D-Wash.) and “deeply frightening” by Sen. Richard Blumenthal (D-Conn.).
Duffy’s directive embraces pronatalism—a once-fringe right-wing ideology that has found a comfortable home in the current administration. (Vice President JD Vance, President Donald Trump and Elon Musk have around 22 kids between them.) Pronatalists believe that having lots of children is an urgent social project—at least for those living in the United States and Europe—in order to “maintain population levels, support economic growth, and preserve cultural and national identities.” And although not usually mentioned in the same breath, pronatalism fits cozily aside the Trump...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...